Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

(2015) Ester Cantó et al.   BRAIN

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

(2015) S Modvig et al.   Multiple Sclerosis Journal

Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins

(2015) Gijsbert P van Nierop et al.   Multiple Sclerosis Journal

Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis

(2015) S Modvig et al.   Multiple Sclerosis Journal

Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins

(2015) Gijsbert P van Nierop et al.   Multiple Sclerosis Journal

Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis

(2014) C. Tørring et al.   ACTA NEUROLOGICA SCANDINAVICA

Revised diagnostic criteria of multiple sclerosis

(2014) Ron Milo et al.   AUTOIMMUNITY REVIEWS

Role of Human Natural Killer Cells during Epstein-Barr Virus Infection

(2014) Christian Muenz   CRITICAL REVIEWS IN IMMUNOLOGY

High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+T cells

(2014) Andreas Lossius et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Biomarkers of treatment response in multiple sclerosis

(2014) Dorothea Buck et al.   Expert Review of Neurotherapeutics

Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases

(2014) S. Han et al.   JOURNAL OF IMMUNOLOGY

Epstein-Barr Virus in the Central Nervous System and Cervical Lymph Node of a Patient With Primary Progressive Multiple Sclerosis

(2014) Barbara Serafini et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study

(2014) R Mancuso et al.   Multiple Sclerosis Journal

The Charcot Lecture | Beating MS: A story of B cells, with twists and turns

(2014) Stephen L Hauser   Multiple Sclerosis Journal

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

(2014) S. Gnanapavan et al.   NEUROLOGY

Transcriptomic Profile Reveals Gender-Specific Molecular Mechanisms Driving Multiple Sclerosis Progression

(2014) Haritz Irizar et al.   PLoS One

Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis

(2014) Clementina E. Cocuzza et al.   PLoS One

Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis

(2013) Paul L. McCormack   DRUGS

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls

(2013) Dorothee Nickles et al.   HUMAN MOLECULAR GENETICS

Gene expression analysis of relapsing–remitting, primary progressive and secondary progressive multiple sclerosis

(2013) R Ratzer et al.   Multiple Sclerosis Journal

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

(2013) Martin Stangel et al.   Nature Reviews Neurology

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients

(2013) Massimo Filippi et al.   NEUROLOGICAL SCIENCES

Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta

(2013) Marta F. Bustamante et al.   PLoS One

The pathogenesis of Epstein–Barr virus persistent infection

(2013) David A Thorley-Lawson et al.   Current Opinion in Virology

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis

(2013) Daniela F. Angelini et al.   PLoS Pathogens

Multiple sclerosis

(2012) Alyssa Nylander et al.   JOURNAL OF CLINICAL INVESTIGATION

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

(2012) Jeppe Romme Christensen et al.   Journal of Neuroinflammation

MS risk genes are transcriptionally regulated in CSF leukocytes at relapse

(2012) Margareta Jernås et al.   Multiple Sclerosis Journal

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation

(2012) Bibiana Bielekova et al.   PLoS One

Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation

(2012) Andreas Lossius et al.   Viruses-Basel

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Autoimmune disease: A role for new anti-viral therapies?

(2011) David H. Dreyfus   AUTOIMMUNITY REVIEWS

Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria

(2011) H. Lassmann et al.   BRAIN

Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse

(2011) Ana Longhini et al.   Journal of Neuroinflammation

Unknown

(2011) J Lindsey et al.   MOLECULAR MEDICINE

Association of innate immune activation with latent Epstein-Barr virus in active MS lesions

(2011) J. S. Tzartos et al.   NEUROLOGY

Systematic review of genome-wide expression studies in multiple sclerosis

(2011) A. K. Kemppinen et al.   BMJ Open

Epstein–Barr Virus Infection and Multiple Sclerosis: A Review

(2010) Alberto Ascherio et al.   Journal of Neuroimmune Pharmacology

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

(2009) Jan D. Lünemann et al.   ANNALS OF NEUROLOGY

A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis

(2009) M. Comabella et al.   BRAIN

Epstein–Barr virus and multiple sclerosis

(2009) Marco Salvetti et al.   CURRENT OPINION IN NEUROLOGY

Intrathecal immune responses to EBV in early MS

(2009) Emilie Jaquiéry et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers

(2009) M. Khademi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Gene expression profiling in multiple sclerosis: A disease of the central nervous system, but with relapses triggered in the periphery?

(2009) Boel Brynedal et al.   NEUROBIOLOGY OF DISEASE

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies

(2008) Michel Noutsias et al.   BMC MOLECULAR BIOLOGY

The effects of natalizumab on the innate and adaptive immune system in the central nervous system

(2008) Olaf Stüve   JOURNAL OF THE NEUROLOGICAL SCIENCES

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

(2008) JW Lindsey et al.   Multiple Sclerosis Journal

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients

(2008) Lisa G. M. van Baarsen et al.   PLoS One

Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis

(2008) Bettina Kuenz et al.   PLoS One